Buchholz
TL2 Member · Pisa, IT
Here for the documentation. Occasionally files a wiki request when a page has drifted out of date.
Joined 6 May 2025 · last posted 1d
90 posts, newest first. Showing up to 150.
-
[2026 update] Documenting an adverse event properly Replied, post #23 · Safety › Adverse events · 27 Jul 2026 · 5 likes Nothing here is medical advice, and in this subcategory the phrase is doing more work than in any other on the site.
-
Seven-day rolling means and why weekly readings mislead Replied, post #113 · Outcomes › Progress reports · 26 Jul 2026 · 19 likes Coming back to post #109, because the follow-up matters more than the original answer. The documentation on seven-day rolling is better than this thread and I say that…
-
CJC-1295 with and without DAC: what the modification does Replied, post #119 · Compounds › Secretagogues & GH axis · 22 Jul 2026 · 3 likes Adding the measurement that post #118 says would settle it. I would keep CJC-1295 and the decision it usually gets used for separate in this thread. They are related…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #80 · Practice › Dosing & titration · 20 Jul 2026 · 0 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #87 · Start Here › Welcome · 16 Jul 2026 · 1 like Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #22 · Compounds › Retatrutide · 13 Jul 2026 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Forced degradation studies: designing one that is informative Replied, post #94 · Analytics › Method validation · 9 Jul 2026 · 10 likes Picking up post #93: that is the part I would want checked first. Taking forced degradation studies seriously for a moment rather than deflecting: the honest position…
-
Journal club: STEP 1 and the treatment-policy estimand Replied, post #2 · Evidence › Journal club · 8 Jul 2026 · 0 likes A methods point on STEP 1 rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Why this subcategory is stricter about sourcing than most Replied, post #48 · Compounds › Secretagogues & GH axis · 26 Jun 2026 · 20 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #30 · Documentation › Doc review · 26 Jun 2026 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. Where a review raises something the author disagrees with, recording the disagreement in the…
-
Search filters: what is missing Replied, post #70 · Meta › Site feedback · 17 Jun 2026 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Why the timeline is on the right and not the left — what changed since Replied, post #56 · Meta › Site feedback · 17 Jun 2026 · 2 likes Worth separating two things that post #52 runs together. Timeline: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly…
-
Second pass at: Programming during a large energy deficit Replied, post #28 · Nutrition & Training › Resistance training · 15 Jun 2026 · 8 likes Worth separating two things that post #24 runs together. Where training is new, the early gains are largely neural, which is why they can appear even during a deficit…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #2 · Analytics › Home & field testing · 2 Jun 2026 · 29 likes Reconstitution behaviour is a legitimate home observation. A cake that will not dissolve, a solution that hazes, visible particulate — all are real information and all…
-
Blinding yourself: practical methods and their limits Replied, post #28 · Research Methods › N-of-1 designs · 24 May 2026 · 0 likes The bit of blinding yourself that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #39 · Practice › Dosing & titration · 20 May 2026 · 12 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #45 · Practice › Interactions · 16 May 2026 · 0 likes Everything in post #44 holds. The case it does not cover is the one I have. Supplements and herbs: many have no established interaction. Some do. If you are taking…
-
Reading a home test result without over-claiming Replied, post #35 · Analytics › Home & field testing · 8 May 2026 · 16 likes An update on my earlier reading a home test result post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #52 · Practice › Administration · 16 Apr 2026 · 2 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Revisiting: Absolute versus relative contraindications Replied, post #66 · Safety › Contraindications · 14 Apr 2026 · 13 likes I would put moderate confidence on the mainstream reading of Absolute versus relative contraindications and no more. That is not scepticism for its own sake; it is…
-
Spreadsheets: an appreciation — what changed since Replied, post #18 · Lounge › Off topic · 13 Apr 2026 · 5 likes Where the Spreadsheets reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
When a dose reduction is the correct response to a side effect Replied, post #7 · Practice › Dosing & titration · 22 Mar 2026 · 19 likes Holding at a dose that is working is a legitimate position and it is not what the trial protocols did. The protocols escalated to a target because they were measuring…
-
A staff appointment, and what the role involves Replied, post #3 · Meta › Announcements · 19 Mar 2026 · 0 likes Taking post #2 at face value and following it one step further. Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions…
-
Measurement error in a self-reported exposure Replied, post #102 · Evidence › Study critique · 27 Feb 2026 · 18 likes Narrowing post #99, because the general version has more than one answer. The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is…
-
Measurement error in a self-reported exposure Replied, post #99 · Evidence › Study critique · 26 Feb 2026 · 0 likes Nobody has said the unglamorous part of measurement error yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #5 · Evidence › Journal club · 22 Feb 2026 · 10 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. The version of orforglipron phase 2 that I was taught turned out to be a…
-
EU-wide position versus national implementation — what changed since Replied, post #17 · Regional › European Union · 20 Feb 2026 · 26 likes Offering a way to settle eu-wide position versus national implementation rather than another opinion about it. Two measurements, taken the same way, a fortnight apart.…
-
Follow-up: Search filters: what is missing Replied, post #36 · Meta › Site feedback · 18 Feb 2026 · 2 likes The arithmetic in post #33 is right; the assumption feeding it is the part to check. Genuine question rather than a rhetorical one: has anyone here actually observed…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #92 · Analytics › Mass spectrometry · 15 Feb 2026 · 10 likes An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified backbone gives a mismatch that is not an error.…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #77 · Analytics › Mass spectrometry · 14 Feb 2026 · 26 likes The arithmetic in post #76 is right; the assumption feeding it is the part to check. Combining a chromatographic result with a mass result is genuinely orthogonal…
-
Coming back to: Training through a dose escalation week Replied, post #20 · Nutrition & Training › Resistance training · 2 Feb 2026 · 30 likes Post #19 is right about the mechanism and I think understates the practical bit. Cardio and resistance: the interaction between energy-intense cardiovascular training…
-
About the Bloodwork category Replied, post #3 · Clinical › Bloodwork · 26 Jan 2026 · 32 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Absence of evidence and evidence of absence Replied, post #12 · Research Methods › Statistics · 7 Jan 2026 · 30 likes Post #8 and I disagree about the size of the effect, not about the direction. Confounding: a third variable explains an apparent association. In randomised data,…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #12 · Practice › Storage & stability · 1 Jan 2026 · 0 likes Trying to state the storing lyophilised material long term position in a way that someone who disagrees would recognise as fair, because I do not think the version in…
-
Adolescents: a distinct evidence base — one year on Replied, post #49 · Clinical › Special populations · 31 Dec 2025 · 0 likes Practical note on Adolescents: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
-
Coming back to: Payment mechanics and the recovery options that do not exist Replied, post #8 · Sourcing › Payments · 28 Dec 2025 · 16 likes I read post #4 twice before replying, because I had assumed the opposite. A first order deliberately smaller than you need is the standard risk-limiting approach here…
-
About the Other compounds category Replied, post #13 · Compounds › Other compounds · 26 Dec 2025 · 3 likes The arithmetic in post #11 is right; the assumption feeding it is the part to check. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #10 · Compounds › Semaglutide · 18 Nov 2025 · 30 likes On post #8 — agreed on the reasoning, with one qualification. Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation…
-
Gauge and length selection for subcutaneous injection Replied, post #48 · Devices › Syringes & needles · 8 Nov 2025 · 19 likes Picking up post #47: that is the part I would want checked first. I have no financial interest in anything named in this thread and I want to say so before I comment on…
-
Reading an interaction checker output critically Replied, post #33 · Practice › Interactions · 31 Oct 2025 · 30 likes Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here. I would put a…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #80 · Documentation › Doc review · 24 Oct 2025 · 29 likes Post #77 answers the question as asked. The question underneath it is different. Promotion criteria has been discussed here with more heat than it deserves, mostly…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #30 · Compounds › Semaglutide · 20 Oct 2025 · 23 likes STEP 1 and STEP 4 are two different questions. The first asks what happens when treatment is added; the second asks what happens when it is withdrawn after a run-in.…
-
New subcategory: rationale and scope Replied, post #44 · Meta › Announcements · 17 Oct 2025 · 6 likes The number people quote for new subcategory is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #11 · Evidence › Journal club · 17 Oct 2025 · 23 likes The arithmetic in post #8 is right; the assumption feeding it is the part to check. Sessions on negative or null results are consistently the most instructive and the…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #32 · Start Here › Welcome · 15 Oct 2025 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #36 · Wellbeing › Mental health · 11 Oct 2025 · 4 likes Post #34 put the caveat in the right place and I want to underline it. If you are in crisis, contact a local emergency or crisis service rather than posting. A…
-
Airline travel with a temperature-sensitive injectable Replied, post #7 · Devices › Cold chain · 10 Oct 2025 · 30 likes Confirming post #4 from a second method, which matters more than confirming it from a second person. The honest summary: pack quality is visible, transit history is…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #113 · Compounds › Retatrutide · 18 Sep 2025 · 13 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #73 · Evidence › Study critique · 14 Sep 2025 · 6 likes Post #72 is right about the mechanism and I think understates the practical bit. The bit of Reverse causation that nobody enjoys is that the answer changes depending on…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #11 · Meta › Announcements · 14 Sep 2025 · 17 likes Adding a null result on Scheduled maintenance. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Tracking that stops updating and then resumes — the long version Replied, post #11 · Sourcing › Logistics · 3 Sep 2025 · 0 likes Post #10 is right about the mechanism and I think understates the practical bit. Document outcomes rather than forecasting them. A forecast in this category reads as…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #17 · Lounge › Off topic · 2 Sep 2025 · 6 likes Off-topic but genuinely curious: how many people here came in through the analytics side rather than the practical side? The two groups seem to read completely…
-
[2026 update] Splitting an overlong document into two Replied, post #28 · Documentation › Wiki requests · 29 Aug 2025 · 0 likes Picking up post #27: that is the part I would want checked first. The strongest case for a new document is a question that recurs and has a good answer buried in a…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #94 · Access › Insurance & coverage · 26 Aug 2025 · 0 likes Post #91 answers the question as asked. The question underneath it is different. Reading a denial letter has a well-known answer and a correct answer, and the…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #92 · Compounds › Secretagogues & GH axis · 23 Aug 2025 · 0 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
Are there stupid questions here? A staff answer, at length Replied, post #87 · Start Here › Welcome · 18 Aug 2025 · 4 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #55 · Evidence › Journal club · 17 Aug 2025 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #77 · Access › Insurance & coverage · 12 Aug 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
A ten-fold dose error caught before injection — one year on Replied, post #52 · Devices › Syringes & needles · 2 Aug 2025 · 25 likes This follows post #51 rather than contradicting it. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous…
-
Coming back to: Official shortage notices and what they authorise Replied, post #70 · Access › Shortages · 27 Jul 2025 · 3 likes Pharmacy-level availability varies enormously during a shortage, so two honest accounts from the same city can be opposite. If anyone has run this properly I would…
-
Appeal templates and why they are deliberately unemotional — one year on Started this topic · Access › Insurance & coverage · 13 Jul 2025 · 12 likes Appeal templates and why they are deliberately unemotional — one year on Writing it up because I had to work it out twice and would rather nobody else did. A narrow…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #16 · Evidence › Journal club · 23 Jun 2025 · 6 likes Picking up post #13: that is the part I would want checked first. Bringing the previous paper on the same question makes the session much better and doubles the…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #12 · Compounds › Semaglutide · 31 May 2025 · 0 likes The 165 to 184 hour half-life range gets quoted as a fixed number. It is a range across a studied population, and individual clearance varies enough that a person's own…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #27 · Devices › Cold chain · 13 May 2025 · 3 likes Worth separating two things that post #25 runs together. The reason Airline travel is hard to answer is that the obvious measurement and the relevant quantity are not…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #62 · Compounds › Secretagogues & GH axis · 27 Apr 2025 · 10 likes Pulsatile secretion: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
-
Residual solvents and scavengers: what is looked for Replied, post #16 · Analytics › Impurities & related substances · 24 Apr 2025 · 5 likes Deamidation at asparagine or glutamine adds approximately one dalton and frequently produces a close-eluting pair. It is the impurity most likely to be integrated into…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #87 · Compounds › Semaglutide · 22 Apr 2025 · 0 likes Renal outcomes moved this compound out of the metabolic-only conversation. FLOW reported on kidney endpoints in people with type 2 diabetes and chronic kidney disease,…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #19 · Practice › Reconstitution · 11 Apr 2025 · 0 likes The bit of over-dilution that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #4 · Analytics › Home & field testing · 4 Apr 2025 · 0 likes Checked the quantitation claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Started this topic · Evidence › Journal club · 29 Mar 2025 · 4 likes Posting this under the heading it deserves: Journal club: indirect comparison between two programmes, defended and attacked — one year on Everything below is what sits…
-
Reading order for a first week here, and what to skip until later Replied, post #57 · Start Here › Welcome · 29 Mar 2025 · 0 likes An honest declaration on reading order: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Transit times by route, from a logged dataset — the long version Replied, post #65 · Sourcing › Logistics · 28 Feb 2025 · 0 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #108 · Data & Tools › Calculators · 27 Feb 2025 · 2 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives.
-
Second pass at: Regression to the mean in progress reports Replied, post #58 · Research Methods › Statistics · 17 Feb 2025 · 20 likes Medians and means diverge for skewed distributions, and most of the quantities discussed here are skewed. Which one a paper reports is a choice worth noticing. Nothing…
-
Protein density versus volume when you cannot eat much Replied, post #87 · Nutrition & Training › Protein & intake · 7 Feb 2025 · 7 likes Nothing here is medical or dietetic advice, and a dietitian is the professional this subcategory most often recommends. I would not lead a decision with this, but I…
-
Protein density versus volume when you cannot eat much Replied, post #62 · Nutrition & Training › Protein & intake · 3 Feb 2025 · 8 likes Post #59 describes the usual case. This is about the unusual one. Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #107 · Analytics › Method validation · 31 Dec 2024 · 9 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #29 · Compounds › Oral incretins · 26 Dec 2024 · 32 likes Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial or across two. Across two, the populations differ and…
-
A page that has drifted out of date and needs a maintainer Replied, post #38 · Documentation › Wiki requests · 10 Dec 2024 · 0 likes Picking up post #37: that is the part I would want checked first. Suggesting content for a page: if you know a maintained page is missing something important, post a…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #18 · Practice › Side effects · 22 Nov 2024 · 5 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Time to steady state after a dose increase Replied, post #10 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 7 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
-
Buffers, pH and why a formulation is a formulation Started this topic · Pharmacology › Formulation chemistry · 24 Oct 2024 · 7 likes Buffers, pH and why a formulation is a formulation Writing it up because I had to work it out twice and would rather nobody else did. A formulation question rather than…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #50 · Clinical › Comorbidities · 17 Oct 2024 · 7 likes The claim about Hypertension improvement upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says…
-
Why a preprint's supplementary material is often the best part Replied, post #20 · Evidence › Preprints · 11 Sep 2024 · 17 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #43 · Analytics › COA interpretation · 2 Sep 2024 · 3 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #22 · Evidence › Preprints · 2 Aug 2024 · 0 likes Everything in post #20 holds. The case it does not cover is the one I have. Do not build anything on a preprint that you would mind rebuilding: if the preprint later…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #14 · Sourcing › Red flags · 27 Jul 2024 · 0 likes Where I part company with post #12, and it is a narrow parting. Pricing far outside the range is worth one more sentence than it usually gets, and the sentence is the…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #56 · Practice › Dosing & titration · 22 Jul 2024 · 0 likes Taking four-week escalation interval seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
Second pass at: Retatrutide dose escalation in the published trials Started this topic · Compounds › Retatrutide · 14 Jul 2024 · 48 likes Second pass at: Retatrutide dose escalation in the published trials — setting out what I have, and where I think it stops being reliable. Two things I would like…
-
Second pass at: Albumin binding and how it produces a long half-life Started this topic · Pharmacology › Pharmacokinetics · 22 Jun 2024 · 22 likes Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that. A narrow…